{{Rsnum
|rsid=3750518
|Gene=MAN1B1
|Chromosome=9
|position=137088416
|Orientation=minus
|GMAF=0.4812
|Gene_s=MAN1B1,RPL17P38
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.2 | 46.9 | 38.9
| HCB | 44.5 | 46.0 | 9.5
| JPT | 43.4 | 45.1 | 11.5
| YRI | 23.8 | 49.7 | 26.5
| ASW | 15.8 | 57.9 | 26.3
| CHB | 44.5 | 46.0 | 9.5
| CHD | 46.3 | 41.7 | 12.0
| GIH | 20.8 | 51.5 | 27.7
| LWK | 15.5 | 46.4 | 38.2
| MEX | 19.0 | 43.1 | 37.9
| MKK | 17.3 | 46.2 | 36.5
| TSI | 12.7 | 44.1 | 43.1
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3750518
|Name_s=
|Gene_s=MAN1B1
|Feature=
|Evidence=PubMed ID:18451141
|Annotation=This SNP at chromosome 9 is significantly associated with HNRPD expression (located on chromosome 4), and daunorubicin IC50 in CEU population using International HapMap cell lines.
|Drugs=daunorubicin
|Drug Classes=
|Diseases=Drug Toxicity
|Curation Level=Curated
|PharmGKB Accession ID=PA162263545
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3750518
|overall_frequency_n=1890
|overall_frequency_d=4586
|overall_frequency=0.412124
|n_genomes=37
|n_genomes_annotated=0
|n_haplomes=51
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}